Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Neuroradiology
Published in: Clinical Neuroradiology 1/2019

01-03-2019 | Original Article

Characterization of Skull Base Lesions Using Pseudo-Continuous Arterial Spin Labeling

Authors: B. Geerts, D. Leclercq, S. Tezenas du Montcel, B. Law-ye, S. Gerber, D. Bernardeschi, D. Galanaud, D. Dormont, N. Pyatigorskaya

Published in: Clinical Neuroradiology | Issue 1/2019

Login to get access

Abstract

Purpose

Pseudo-continuous arterial spin labeling (pCASL) is a non-invasive magnetic resonance (MR) perfusion technique. Our study aimed at estimating the diagnostic performance of the pCASL sequence in assessing the perfusion of skull base lesions both qualitatively and quantitatively and at providing cut-off values for differentiation of specific skull base lesions.

Methods

In this study 99 patients with histopathologically confirmed skull base lesions were retrospectively enrolled. Based on a pathological analysis, the lesions were classified as hypervascular and non-hypervascular. Patients were divided into two subgroups according to the anatomical origin of each lesion. The MRI study included pCASL and 3D T1-weighted fat-saturated post-contrast sequences. Of the patients seven were excluded due to technical difficulties or patient movement. The lesions were classified by two raters, blinded to the diagnosis as either hyperperfused or non-hyperperfused, based on the pCASL sequence. The normalized tumor blood flow (nTBF) of each lesion was determined. Qualitative and quantitative characteristics of hypervascular and non-hypervascular lesions were compared.

Results

Visual assessment enabled correct classification of 98% of the lesions to be performed. Quantitatively, we found significant differences between the nTBF values for hypervascular and non-hypervascular lesions (p < 0.001) and provided cut-off values, allowing meningioma and schwannoma to be distinguished from meningioma and adenoma. Significant differences were also found within the hypervascular group, namely, paraganglioma was more hyperperfused than meningioma (p = 0.003) or metastases (p = 0.009).

Conclusion

The present study demonstrates the high diagnostic performance of pCASL in characterizing skull base lesions by either visual assessment or nTBF quantification. Adding the pCASL sequence to the conventional protocol of skull base assessment can be recommended.
Literature
1.
Folkman J. Seminars in Medicine of the Beth Israel, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 1995;333:1757–63.CrossRefPubMed
2.
Boxerman JL, Shiroishi MS, Ellingson BM, Pope WB. Dynamic Susceptibility Contrast MR Imaging in Glioma. Review of current clinical practice. Magn Reson Imaging Clin N Am. 2016;24:649–70.CrossRefPubMed
3.
Järnum H, Steffensen EG, Knutsson L, Fründ ET, Simonsen CW, Lundbye-Christensen S, Shankaranarayanan A, Alsop DC, Jensen FT, Larsson EM. Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging. Neuroradiology. 2010;52:307–17.CrossRefPubMed
4.
Hartkamp NS, van Osch MJ, Kappelle J, Bokkers RP. Arterial spin labeling magnetic resonance perfusion imaging in cerebral ischemia. Curr Opin Neurol. 2014;27(1):42–53.CrossRefPubMed
5.
Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA. Arterial Spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol. 2008;29:1228–34.CrossRefPubMed
6.
7.
Grade M, Hernandez Tamames JA, Pizzini FB, Achten E, Golay X, Smits M. A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice. Neuroradiology. 2015;57:1181–202.CrossRefPubMedPubMedCentral
8.
Kimura H, Takeuchi H, Koshimoto Y, Arishima H, Uematsu H, Kawamura Y, Kubota T, Itoh H. Perfusion imaging of meningioma by using continuous arterial spin-labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features. AJNR Am J Neuroradiol. 2006;27:85–93.PubMed
9.
Amukotuwa SA, Yu C, Zaharchuk G. 3D pseudocontinuous arterial spin labeling in routine clinical practice: a review of clinically significant artifacts. J Magn Reson Imaging. 2016;43:11–27.CrossRefPubMed
10.
Wong AM, Yan FX, Liu HL. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI. J Magn Reson Imaging. 2014;39:427–33.CrossRefPubMed
11.
Fujima N, Kudo K, Tsukahara A, Yoshida D, Sakashita T, Homma A, Tha KK, Shirato H. Measurement of Tumor Blood Flow in Head and Neck Squamous Cell Carcinoma by Pseudo-Continuous Arterial Spin Labeling: Comparison With Dynamic Contrast-Enhanced MRI. J Magn Reson Imaging. 2015;41:983–91.CrossRefPubMed
12.
Sakai N, Koizumi S, Yamashita S, Takehara Y, Sakahara H, Baba S, Oki Y, Hiramatsu H, Namba H. Arterial Spin-Labeled Perfusion Imaging Reflects Vascular Density in Nonfunctioning Pituitary Macroadenomas. AJNR Am J Neuroradiol. 2013;34:2139–43.CrossRefPubMed
13.
Noguchi T, Yoshiura T, Hiwatashi A, Togao O, Yamashita K, Nagao E, Shono T, Mizoguchi M, Nagata S, Sasaki T, Suzuki SO, Iwaki T, Kobayashi K, Mihara F, Honda H. Perfusion imaging of brain tumors using arterial spin-labeling: correlation with histopathologic vascular density. AJNR Am J Neuroradiol. 2008;29:688–93.CrossRefPubMed
14.
Griffith B, Jain R. Perfusion Imaging In Neuro-Oncology: Basic Techniques and Clinical Applications. Radiol Clin North Am. 2015;53:497–511.CrossRefPubMed
15.
Alsop DC, Detre JA, Golay X, Günther M, Hendrikse J, Hernandez-Garcia L, Lu H, MacIntosh BJ, Parkes LM, Smits M, van Osch MJ, Wang DJ, Wong EC, Zaharchuk G. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med. 2015;73:102–16.CrossRefPubMed
16.
Arbab AS, Aoki S, Toyama K, Kumagai H, Arai T, Kabasawa H, Takahashi Y, Araki T. Brain perfusion measured by flow-sensitive alternating inversion recovery (FAIR) and dynamic susceptibility conrast-enhanced magnetic resonance imaging: comparison with nuclear medicin technique. Eur Radiol. 2001;11:635–41.CrossRefPubMed
17.
Yamamoto T, Takeuchi H, Kinoshita K, Kosaka N, Kimura H. Assessment of tumor blood flow and its correlation with histopathologic features in skull base meningiomas and schwannomas by using pseudo-continuous arterial spin labeling images. Eur J Radiol. 2014;83:817–23.CrossRefPubMed
18.
Maeda M, Itoh S, Kimura H, Iwasaki T, Hayashi N, Yamamoto K, Ishii Y, Kubota T. Vascularity of meningiomas and neuromas: assessment with dynamic susceptibility-contrast MR imaging. AJR Am J Roentgenol. 1994;163:181–6.CrossRef
19.
Jiang J, Zhao L, Zhang Y, Zhang S, Yao Y, Qin Y, Wang CY, Zhu W. Comparative analysis of arterial spin labeling and dynamic susceptibility contrast perfusion imaging for quantitative perfusion measurements of brain tumors. Int J Clin Exp Pathol. 2014;7:2790–9.PubMedPubMedCentral
20.
van den Berg R. Imaging and management of head and neck paragangliomas. Eur Radiol. 2005;15:1310–8.CrossRefPubMed
21.
Bush ML, Pritchett C, Packer M, Ray-Chaudhury A, Jacob A. Hemangioblastoma of the cerebellopontine angle. Arch Otolaryngol Head Neck Surg. 2010;136:734–8.CrossRefPubMed
22.
23.
Chang PC, Fischbein NJ, Holliday RA. Central Skull Base Osteomyelitis in Patients without Otitis Externa: Imaging Findings. AJNR Am J Neuroradiol. 2003;24:1310–6.PubMed
24.
Ginat DT, Bokhari A, Bhatt S, Dogra V. Inflammatory pseudotumors of the head and neck in pathology-proven cases. J Neuroradiol. 2012;39:110–5.CrossRefPubMed
25.
Guo SY, Cai XQ, Ma J, Wang WY, Lu G. Diagnosis of concomitant pituitary adenoma and Rathke’s cleft cyst with magnetic resonance imaging. Int J Surg. 2015;18:191–5.CrossRefPubMed
26.
Kothary N, Law M, Cha S, Zagzag D. Conventional and perfusion MR imaging of parafalcine chondrosarcoma. AJNR Am J Neuroradiol. 2003;24:245–8.PubMed
27.
Corrales CE, Fischbein N, Jackler RK. Imaging Innovations in Temporal Bone Disorders. Otolaryngol Clin North Am. 2015;48:263–80.CrossRefPubMed
28.
Akkari M, Gabrillargues J, Saroul N, Pereira B, Russier M, Mom T, Gilain L. Contribution of magnetic resonance imaging to the diagnosis of middle ear cholesteatoma: Analysis of a series of 97 cases. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131:153–8.CrossRefPubMed
29.
Cerase A, Tarantino A, Gozzetti A, Muccio CF, Gennari P, Monti L, Di Blasi A, Venturi C. Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay. Neuroradiology. 2008;50:665–74.CrossRefPubMed
30.
Siemonsen S, Fitting T, Thomalla G, Krützelmann A, Fiehler J. Visual assessment of magnetic resonance imaging perfusion lesions in a large patient group. Clin Neuroradiol. 2012;22:305–13.CrossRefPubMed
31.
Turowski B, Schramm P. An Appeal to Standardize CT-and MR-Perfusion. Clin Neuroradiol. 2015;25 Suppl 2:205–10.CrossRefPubMed
32.
Radbruch A, Bendszus M. Advanced MR Imaging in Neuro-oncology. Clin Neuroradiol. 2015;25 Suppl 2:143–9.CrossRefPubMed
33.
Abe T, Mizobuchi Y, Sako W, Irahara S, Otomi Y, Obama Y, Nakajima K, Khashbat D, Majigsuren M, Kageji T, Nagahiro S, Harada M. Clinical Significance of Discrepancy between Arterial Spin Labeling Images and Contrast-enhanced Images in the Diagnosis of Brain Tumors. Magn Reson Med Sci. 2015;14:313–9.CrossRefPubMed
34.
Wong AM, Yan FX, Liu HL. Comparison of Three-Dimensional Pseudo-continuous Arterial Spin Labeling Perfusion Imaging With Gradient-Echo and Spin-Echo Dynamic Susceptibility Contrast MRI. J Magn Reson Imaging. 2014;39:427–33.CrossRefPubMed
35.
Steketee RM, Mutsaerts HJ, Bron EE, van Osch MJ, Majoie CB, van der Lugt A, Nederveen AJ, Smits M. Quantitative Functional Arterial Spin Labeling (fASL) MRI – Sensitivity and Reproducibility of Regional CBF Changes Using Pseudo-Continuous ASL Product Sequences. PLoS One. 201514;10:e0132929.
36.
Thomas AJ, Wiggins RH 3rd, Gurgel RK. Nonparaganglioma jugular foramen tumors. Otolaryngol Clin North Am. 2015;48:343–59.CrossRefPubMed
37.
Moreno-García C, González-García R, García MA, Monje F. Vagus Nerve Paraganglioma: Radiological Features We Should Be Aware of. J Maxillofac Oral Surg. 2015;14:1013–5.CrossRefPubMedPubMedCentral
38.
He W, Chen F, Dalm B, Kirby PA, Greenlee JD. Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis. Pituitary. 2015;18:159–68.CrossRefPubMed
39.
Hong P, Taylor SM, Trites JR, Bullock M, Nasser JG, Hart RD. Chondrosarcoma of the head and neck: report of 11 cases and literature review. J Otolaryngol Head Neck Surg. 2009;38:279–85.PubMed
40.
Thomsen HS, Morcos SK, Almén T, Bellin MF, Bertolotto M, Bongartz G, Clement O, Leander P, Heinz-Peer G, Reimer P, Stacul F, van der Molen A, Webb JA; ESUR Contrast Medium Safety Committee. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committe guidelines. Eur Radiol. 2013;23:307–18.CrossRefPubMed
41.
42.
Mutsaerts HJ, van Osch MJ, Zelaya FO, Wang DJ, Nordhøy W, Wang Y, Wastling S, Fernandez-Seara MA, Petersen ET, Pizzini FB, Fallatah S, Hendrikse J, Geier O, Günther M, Golay X, Nederveen AJ, Bjørnerud A, Groote IR. Multi-vendor reliability of arterial spin labeling perfusion MRI using a near-identical sequence: implications for multi-center studies. Neuroimage. 2015;113:143–52.CrossRefPubMed
43.
Chen Y, Wang DJ, Detre JA. Test-retest reliability of arterial spin labeling with common labeling strategies. J Magn Reson Imaging. 2011;33:940–9.CrossRefPubMedPubMedCentral
44.
Jung BC, Arevalo-Perez J, Lyo JK, Holodny AI, Karimi S, Young RJ, Peck KK. Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI. J Neuroimaging. 2016;26:240–6.CrossRefPubMed
Metadata
Title
Characterization of Skull Base Lesions Using Pseudo-Continuous Arterial Spin Labeling
Authors
B. Geerts
D. Leclercq
S. Tezenas du Montcel
B. Law-ye
S. Gerber
D. Bernardeschi
D. Galanaud
D. Dormont
N. Pyatigorskaya
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Published in
Clinical Neuroradiology / Issue 1/2019
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-017-0623-7

Other articles of this Issue 1/2019

Clinical Neuroradiology 1/2019 Go to the issue

Correspondence

Osteophyte piercing of the dura

Correspondence

Transpopliteal Access for Intraoperative Spinal Angiography with Combined Percutaneous Treatment of Spinal Hemangioma

Original Article

3D Fast Spin-Echo T1 Black-Blood Imaging for the Preoperative Detection of Venous Sinus Invasion by Meningioma

Review Article

Central Nervous System Tuberculosis

Original Article

Computed Tomography Perfusion is a Useful Adjunct to Computed Tomography Angiography in the Diagnosis of Brain Death

Original Article

Low-Dose CCT to Exclude Contraindications to Lumbar Puncture